Women are told early and often that we must learn to choose. A lane, a discipline, a specialty, and burrow into it until the world blurs in the periphery.
In many ways, my life has proven antithetical to the idea of a singularity.
I have moved through rooms as an engineer, as a vaccine developer, as a formulation scientist, and as someone who hunts for platform technologies and translates them into products that will thrive off the bench. I have walked the academic corridors where hypotheses are treated as currency. I have worked in an industry where scale is the only language that matters. I have learned regulatory vocabulary. I have learned commercial vocabulary. I have learned how funding decisions are made and how they are avoided.
For a long time, this breadth felt like a liability. The world rewards the visibly singular. The specialist is easier to categorise. Easier to fund. Easier to explain.
The generalist is harder to market.
But what looks like diffusion is often just latent convergence.
And Misala is my convergence.
Focus, for me, is not the narrowing of skill. It is the deliberate alignment of it.
Women's health is often spoken about as a niche, a subcategory of medicine concerned primarily with fertility, pregnancy, and perhaps menopause if the room is feeling expansive. Even then, the conversation collapses quickly into maternal mortality statistics or cervical cancer screening targets, as though the totality of a woman's biological experience can be compressed into reproduction and disease.
It is a profoundly narrow framing.
Women's health is hormonal transitions. It is microbiomes. It is metabolic shifts. It is sleep architecture. It is immune modulation. It is mental load. It is how stress expresses itself physically. It is libido and dryness and recurrent infections and fatigue that is dismissed as "normal". It is perimenopause long before menopause is named. It is postpartum long after the baby is healthy and everyone has stopped asking about the mother.
The field does not lack complexity. It lacks integration.
Too often, we treat women's bodies in fragments with gynaecology in one building, psychiatry in another, immunology in another, cardiology somewhere adjacent but never central. The lived experience of being in a woman's body does not compartmentalise so politely. Yet the system insists on it.
Misala does not.
If my career appears scattered, it is because I have been gathering tools.
Formulation science teaches you to think in systems: how compounds interact, how delivery mechanisms alter outcomes, how stability determines viability. Vaccine development teaches you about population-level impact and the ruthless discipline of safety. Technology transfer teaches you that brilliance inside a lab is meaningless unless it survives contact with regulation, manufacturing, distribution, and cost constraints. Commercialisation teaches you that intention is irrelevant without adoption.
All of that now bends toward one focal point.
Women’s health in Africa cannot be solved in a single stroke. It requires both immediacy and patience. It requires products women can access today, that is, wellness solutions that support balance, recovery, and restoration, and it requires diagnostic infrastructure that allows clinicians to treat correctly rather than repeatedly.
That is why we begin where we are.
Wellness, because it allows us to enter women's lives directly and build trust in language that is human and accessible.
Diagnostics, because without clarity at the clinical level, recurrence becomes routine and symptoms become cycles.
The temptation, when one has trained across disciplines, is to build everything at once. To design the full stack immediately. To chase the grand solution.
Focus says: begin here. Build this well. Let the rest assemble in time.
The next phase of posts will be less autobiographical and more technical. We will talk about formulation choices and microbiomes and regulatory pathways. We will discuss why certain botanicals are underutilised and how diagnostics can influence prescribing behavior. We will move from interior reflection to exterior construction.
But I wanted to end this first chapter with clarity.
I am not building a women's health company because I lack direction.
I am building it because all my directions point here.
And if women's health has been treated as narrow, as secondary, as peripheral to the "real" work of medicine, then our focus is simple:
We expand the frame.